Peter Greenleaf, Director at Pelthos Therapeutics Inc. (PTHS), sold 797 shares at $20.52 ($17K) on 2026-04-02, disclosed to the SEC on 2026-04-06.
Scheduled sale ($17k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.52 | 420 | $9K | 51.7% |
| 2 | $21.36 | 377 | $8K | 48.3% |
| Total | $20.92 avg | 797 | $17K | 100% |
| Filing → |
| AUPH | SELL | 2024-03-07 | $1.4M | — | Filing → |
| AUPH | SELL | 2024-02-22 | $580K | — | Filing → |
| AUPH | SELL | 2022-03-04 | $218K | — | Filing → |